This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Laparoscopic cholecystectomy is a minimally invasive surgical procedure that involves the removal of the gallbladder. This procedure has revolutionized the treatment of gallbladder diseases by providing a less invasive alternative to traditional open cholecystectomy. During a laparoscopic cholecystectomy, several small incisions are made in the abdomen. Through these incisions, a laparoscope (a thin, lighted tube) is inserted, which allows the surgeon to view the internal anatomy of the abdominal cavity. The surgeon then inserts special instruments through the other incisions, which are used to dissect, divide, and remove the gallbladder. The procedure is typically performed under general anesthesia, though local or regional anesthesia may be used in some cases. The entire procedure can take anywhere from 45 minutes to two hours, depending on the complexity of the procedure. The primary benefit of laparoscopic cholecystectomy is that it is a less invasive procedure than traditional open cholecystectomy. As such, patients who undergo laparoscopic cholecystectomy usually experience a shorter hospital stay, a faster recovery time, and less pain than those who have open cholecystectomy. Additionally, laparoscopic cholecystectomy can be used to diagnose and treat certain gallbladder diseases, such as gallstone disease and chronic cholecystitis. Due to the relative safety and effectiveness of laparoscopic cholecystectomy, it is now the preferred method of gallbladder removal. This procedure is typically performed in an outpatient setting and can be completed in a single visit. Patients should always discuss the risks and benefits of the procedure with their surgeon prior to undergoing the procedure.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States